Acuity has advised longstanding client Alesi Surgical Limited (formally Asalus Medical Instruments) on a further investment of £2.1m.
Alesi Surgical, a spin-out from Cardiff University, will use the funding to drive the commercialisation of its award-winning lead product, Ultravision.
Managing Director of Alesi Surgical, Dominic Griffiths, said, “We are delighted with the support Acuity provided us. Having worked with Acuity for many years across multiple investment rounds, their specialist knowledge and in-depth understanding of our company was instrumental in helping us close on this investment round.”
Acuity Legal’s Phil Pugh said, “Clients of the calibre of Alesi continuing to instruct us is a testament to the strength of our Life Sciences team. We continue to provide legal support to Alesi across many fronts, including on their commercial contracts and distribution agreements, and long may this continue.”